Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ramez N Eskander & Krishnansu S Tewari. (2013) Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer. Clinical Pharmacology: Advances and Applications 5, pages 55-61.
Read now
Read now
Taylor J Brueseke & Krishnansu S Tewari. (2013) Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma. Clinical Pharmacology: Advances and Applications 5:sup1, pages 13-19.
Read now
Read now
Gina M. Mantia-Smaldone, Bradley Corr & Christina S. Chu. (2012) Immunotherapy in ovarian cancer. Human Vaccines & Immunotherapeutics 8:9, pages 1179-1191.
Read now
Read now
Articles from other publishers (17)
Nur Fatin Najihah Marzuki & Yusmazura Zakaria. (2023) Medicinal Plants in the Regulation of PD-L1/PD-1 Immune Checkpoint of
Various Human Cancer Cells: A Narrative Review. Current Cancer Therapy Reviews 19:2, pages 117-131.
Crossref
Crossref
Suzanne R. Thibodeaux, Brian B. Barnett, Srilakshmi Pandeswara, Shawna R. Wall, Vincent Hurez, Vinh Dao, Lishi Sun, Benjamin J. Daniel, Michael J. Brumlik, Justin Drerup, Álvaro Padrón, Teresa Whiteside, Ilona Kryczek, Weiping Zou & Tyler J. Curiel. (2021) IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Clinical Cancer Research 27:13, pages 3661-3673.
Crossref
Crossref
Ramesh Duwa, Jee-Heon Jeong & Simmyung Yook. (2021) Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction. Journal of Industrial and Engineering Chemistry 94, pages 62-77.
Crossref
Crossref
Lan Dai, Keqi Song & Wen Di. (2020) Adipocytes: active facilitators in epithelial ovarian cancer progression?. Journal of Ovarian Research 13:1.
Crossref
Crossref
Stephanie Lheureux, Charlie Gourley, Ignace Vergote & Amit M Oza. (2019) Epithelial ovarian cancer. The Lancet 393:10177, pages 1240-1253.
Crossref
Crossref
Xue-qian Qian, Li-li Chen, Qi Cheng, Yang Tian, Xiao-feng Luo & Xiao-yun Wan. (2016) Inhibition of Notch 1 receptor influenced the differentiation of Lin-CD45RA-dendritic cell precursors within ovarian carcinoma microenvironment. BMC Immunology 17:1.
Crossref
Crossref
Suprita A. Tawde, Lipika Chablani, Archana Akalkotkar & Martin J. D'Souza. (2016) Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery. Journal of Controlled Release 235, pages 147-154.
Crossref
Crossref
Susan B. Ingersoll, Sarfraz Ahmad, Hasina C. McGann, Robert K. Banks, Nicole M. Stavitzski, Milan Srivastava, Ghazanfar Ali, Neil J. Finkler, John R. Edwards & Robert W. Holloway. (2015) Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer. Molecular and Cellular Biochemistry 407:1-2, pages 281-287.
Crossref
Crossref
Rikhav Gala, Suprita Tawde, Maurizio Chiriva-Internati & Martin D'Souza. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
195
209
.
K Abiko, N Matsumura, J Hamanishi, N Horikawa, R Murakami, K Yamaguchi, Y Yoshioka, T Baba, I Konishi & M Mandai. (2015) IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. British Journal of Cancer 112:9, pages 1501-1509.
Crossref
Crossref
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
89
122
.
Elena N. Chernova, Vladimir M. Shulkin, Eugenia V. Lysenko, Tatiana N. Lutsenko & Anna G. Boldeskul. (2014) Hydrochemical and biogeochemical features of freshwater and brackish lakes in eastern Sikhote-Alin. Izvestiya TINRO 178:3, pages 157-172.
Crossref
Crossref
Alexandra Snyder, Jaron E. Tepper & Susan F. Slovin. (2013) Perspectives on Immunotherapy in Prostate Cancer and Solid Tumors: Where Is the Future?. Seminars in Oncology 40:3, pages 347-360.
Crossref
Crossref
Kaoru Abiko, Masaki Mandai, Junzo Hamanishi, Yumiko Yoshioka, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Ryusuke Murakami, Ayaka Yamamoto, Budiman Kharma, Kenzo Kosaka & Ikuo Konishi. (2013) PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction. Clinical Cancer Research 19:6, pages 1363-1374.
Crossref
Crossref
Shashi Gujar, Rebecca Dielschneider, Derek Clements, Erin Helson, Maya Shmulevitz, Paola Marcato, Da Pan, Lu-zhe Pan, Dae-Gyun Ahn, Abdulaziz Alawadhi & Patrick WK Lee. (2013) Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation. Molecular Therapy 21:2, pages 338-347.
Crossref
Crossref
Tyler J. Curiel. 2013. Cancer Immunotherapy. Cancer Immunotherapy
3
15
.
Suprita A. Tawde, Lipika Chablani, Archana Akalkotkar, Cherilyn D'Souza, Maurizio Chiriva-Internati, Periasamy Selvaraj & Martin J. D'Souza. (2012) Formulation and evaluation of oral microparticulate ovarian cancer vaccines. Vaccine 30:38, pages 5675-5681.
Crossref
Crossref